Merz Aesthetics


Our brands

The BELOTERO® range of hyaluronic acid fillers is tailor-made to adapt to different facial areas and injection depths, intended to be used to fill wrinkles, restore facial volumes and improve skin quality.1

Find out more

BELOTERO® Revive is the newest addition to our BELOTERO® range, combining hyaluronic acid and glycerol to help revitalise early-onset photodamaged facial skin. By helping to restore the skin’s hydration, reducing pigmentation, improving the texture and general signs of ageing, BELOTERO® Revive treats the early signs of photodamage.2,3

Find out more

The only clinically-proven FDA-cleared treatment that utilises ultrasound with real-time visualisation for precision targeting of deep tissues, stimulating the production of collagen and elastin to lift and tighten the skin. 4–6

Find out more

A semi-permanent dermal filler for lifting and contouring with long-term collagen stimulation. Intended to reduce deeper lines, for dermal and sub-dermal soft tissue augmentation, such as nasolabial folds, marionette lines, cheeks and contouring of the jawline.7

Find out more

1. Prasetyo AD, et al. Clin Cosmet Investig Dermatol. 2016;9:257—280. 2. BELOTERO® Revive Instructions for Use. 3. Merz BELOVE Study, 2019.
4. Fabi SG, et al. J Drugs Dermatol. 2019;18(5):426-432. 5. ULTHERAPY® EU 1001393IFU Rev N IFU, CONTROL UNIT IFU _Final. 6. Ulthera Press Release: Ultherapy® décolletage treatment now FDA-cleared. BioSpace website. Accessed: December 2021.
7. Radiesse®+ Instructions For Use.

Get in touch

    *Mandatory Fields
    What is your enquiry?

    By submitting this information you are giving your authorisation to Merz Aesthetics to contact you in accordance with our Privacy Notice.

    Advancing medicine in aesthetics

    Welcome to
    Merz Aethetics UK & Ireland

    This website is intended for healthcare professionals based in the UK & Ireland.
    If you are a member of the public wishing to access information on our products
    please select the option 'MEMBER OF THE PUBLIC'

    Tell us who you are